ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc. financial statements

ZyVersa Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 24.95M10-K
Cash and equivalentsUSD 101.78K10-Q

ZyVersa Therapeutics, Inc. financials on 6ix · ZyVersa Therapeutics, Inc. on 6ix